日本血液成分分析市场报告（血浆、血小板、白血球、淋巴球、红血球）、产品、技术、流程、应用、最终使用者及地区（2025-2033）

2024年，日本血液分离市场规模达1.426亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到2.529亿美元，2025-2033年期间的复合年增长率（CAGR）为6.08%。癌症、自体免疫疾病和血液相关疾病等慢性疾病发生率的上升，血液分离设备的快速技术进步，医护人员和患者对血液分离程序益处的认识不断提高，以及医疗基础设施的大量投资，都是推动市场发展的一些因素。

血液分离术是一种具有治疗用途的医疗程序，涉及从捐赠者或患者体内分离和提取特定血液成分。该过程使用一种称为血液分离机的精密机器，可以选择性地提取和保留血液成分，例如血浆、血小板、红血球或白血球。根据目标血液成分，分离过程透过离心或过滤实现。血液分离术的主要治疗应用之一是治疗各种疾病，包括自体免疫疾病、血液疾病和神经系统疾病。例如，对于多发性硬化症或重症肌无力等自体免疫疾病，血液分离术可以去除患者血液中的有害抗体，从而减轻疾病的影响。同样，对于白血病等血液疾病，血液分离术有助于收集用于治疗或移植的特定血液成分。此外，它在捐血过程中也发挥着至关重要的作用，可以收集各种医疗所需的特定成分，并将剩余成分送回捐赠者体内。这种定向血液成分采集提高了捐血效率，确保了医疗干预所需的稳定且多样化的血液製品供应。不断发展的血液分离技术持续推动治疗和捐赠相关医疗实践的进步，为临床医生提供了一种强大的工具，可以选择性地管理血液成分，从而造福于面临各种健康挑战的患者。

日本血液分离市场趋势：

日本市场主要受治疗应用范围不断扩大的驱动。同时，血液分离机技术的快速进步也显着促进了市场成长。设备设计、自动化程度和血液成分分离精度的不断创新，提高了血液分离程序的效率和安全性，使其更容易获得，也更受医疗服务提供者的青睐。这些技术进步也缩短了手术时间，提高了患者的舒适度，进一步推动了血液分离技术在临床环境中的应用。此外，慢性疾病和自体免疫疾病的盛行率不断上升，也刺激了对血液分离程序的需求。癌症、自体免疫疾病和血液疾病等疾病通常需要有针对性地提取或采集特定的血液成分，以控制症状或辅助治疗。血液分离是一种至关重要的治疗干预措施，它能够选择性地提取与疾病相关的成分，有助于疾病管理并改善患者的预后。随着慢性疾病负担的持续增加，对血液分离程序作为一种治疗选择的需求预计将增长。此外，血液分离技术的广泛治疗应用也拓展了其市场潜力。除了传统用途外，血液分离术在神经内科、肾臟科、血液科以及其他医学专科领域也得到了广泛的应用。这种多样化的应用使血液分离术成为各种医疗保健场景中用途广泛且极具价值的工具，并推动了其市场的持续成长。此外，医疗保健专业人员对血液分离术在治疗各种疾病方面的益处的认识不断提高，也进一步推动了其应用。

日本血液分离市场细分：

组件洞察：

• 血浆（血浆置换）
• 血小板（血小板单采）
• 白血球（白血球分离术或白血球去除术）
• 淋巴球（淋巴球分离术或淋巴球分离术）
• 红血球（红血球分离术）

产品洞察：

• 装置
• 耗材和试剂
• 软体

技术洞察：

• 离心
• 膜分离
• 选择性吸附

程式见解：

• 捐赠者/自动血液分离术
• 治疗性血液分离术

应用程式洞察：

• 肾臟疾病
• 血液系统疾病
• 神经系统疾病
• 自体免疫疾病
• 其他的

最终用户洞察：

• 血液中心
• 医院
• 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

• 日本血液分离市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本血液分离市场有何影响？
• 日本血液成分分析市场以成分划分是怎样的？
• 日本血液成分分析市场依产品划分是怎样的？
• 日本血液成分分析市场依技术划分是怎样的？
• 日本血液成分分析市场依程序的划分是怎样的？
• 日本血液成分分析市场依应用如何划分？
• 根据最终用户，日本血液成分分析市场的分布是如何的？
• 日本血液分离市场的价值链分为哪些阶段？
• 日本血液分离术的主要驱动因素和挑战是什么？
• 日本血液分离市场的结构是怎么样的？主要参与者是谁？
• 日本血液净化市场的竞争程度如何？

本报告回答的关键问题：

• 日本血液分离市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本血液分离市场有何影响？
• 日本血液成分分析市场以成分划分是怎样的？
• 日本血液成分分析市场依产品划分是怎样的？
• 日本血液成分分析市场依技术划分是怎样的？
• 日本血液成分分析市场依程序的划分是怎样的？
• 日本血液成分分析市场依应用如何划分？
• 根据最终用户，日本血液成分分析市场的分布是怎样的？
• 日本血液分离市场的价值链分为哪些阶段？
• 日本血液分离术的主要驱动因素和挑战是什么？
• 日本血液分离市场的结构是怎么样的？主要参与者是谁？
• 日本血液净化市场的竞争程度如何？

目录

第一章：前言

CHAPTER 2 : Scope and Methodology

• 研究目标
• 利害关係人
• 资料来源
  • 主要来源
  • 次要来源
• 市场评估
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第三章：执行摘要

第四章：日本血液成分采集市场－简介

• 概述
• 市场动态
• 产业趋势
• 竞争情报

第五章：日本血液成分采集市场概况

• 历史与当前市场趋势（2019-2024）
• 市场预测（2025-2033）

第六章：日本血液分离市场-细分：依成分

• 血浆（血浆置换）
  • 概述
• Platelets (Plateletpheresis)
  • 概述
• 白血球（白血球分离术或白血球去除术）
  • 概述
• 淋巴球（淋巴球分离术或淋巴球分离术）
  • 概述
• 红血球（红血球分离术）
  • 概述

第七章：日本血液分离市场-细分：依产品

• 装置
  • 概述
• 耗材和试剂
  • 概述
• 软体
  • 概述

第 8 章：日本血液分离市场 - 细分：按技术

• 离心
  • 概述
• 膜分离
  • 概述
• 选择性吸附
  • 概述

第九章：日本血液分离市场-细分：依程序

• 捐赠者/自动血液分离术
  • 概述
• 治疗性血液分离术
  • 概述

第 10 章：日本血液分离市场 - 细分：按应用

• 肾臟疾病
  • 概述
• 血液系统疾病
  • 概述
• 神经系统疾病
  • 概述
• 自体免疫疾病
  • 概述
• 其他的

第 11 章：日本血液分离市场 - 细分：按最终用户

• 血液中心
  • 概述
• 医院
  • 概述
• 其他的

第 12 章：日本血液分离市场 - 竞争格局

• 概述
• 市场结构
• 市场参与者定位
• 最佳获胜策略
• 竞争仪錶板
• 公司评估象限

第十三章：关键参与者简介

• Company A
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events

第 14 章：日本血液分离市场 - 产业分析

• 驱动因素、限制因素和机会
  • 概述
  • 驱动程式
  • 限制
  • 机会
• 波特五力分析
  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁
• 价值链分析

第 15 章：附录

Japan apheresis market size reached USD 142.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 252.9 Million by 2033, exhibiting a growth rate (CAGR) of 6.08% during 2025-2033. The increasing incidence of chronic diseases such as cancer, autoimmune disorders, and blood-related conditions, the rapid technological advancements in apheresis equipment, the rising awareness among healthcare professionals and patients about the benefits of apheresis procedures, and the heavy investments in healthcare infrastructure are some of the factors propelling the market.

Apheresis, a medical procedure with therapeutic applications, involves the separation and removal of specific blood components from a donor or patient. The process utilizes a sophisticated machine known as an apheresis machine, which allows for the selective extraction and retention of blood components, such as plasma, platelets, red blood cells, or white blood cells. This separation is achieved through centrifugation or filtration, depending on the targeted blood component. One of the primary therapeutic applications of it is in the treatment of various medical conditions, including autoimmune disorders, hematologic diseases, and neurological disorders. For example, in autoimmune diseases like multiple sclerosis or myasthenia gravis, apheresis can remove harmful antibodies from the patient's blood, mitigating the impact of the disease. Similarly, in hematologic disorders like leukemia, apheresis aids in collecting specific blood components for therapeutic use or transplantation. Additionally, it plays a crucial role in blood donation processes, allowing for the collection of specific components needed for various medical treatments while returning the remaining components to the donor. This targeted blood component collection enhances the efficiency of blood donation practices, ensuring a steady and diverse supply of blood products for medical interventions. The evolving field of apheresis continues to contribute to advancements in therapeutic and donation-related medical practices, providing clinicians with a powerful tool to selectively manage blood components to benefit patients facing a spectrum of health challenges.

Japan Apheresis Market Trends:

The market in Japan is majorly driven by the expanding scope of therapeutic applications. In line with this, the rapid advancements in apheresis machine technologies contribute significantly to market growth. Continuous innovations in device design, automation, and precision in blood component separation enhance the efficiency and safety of apheresis procedures, making them more accessible and attractive to healthcare providers. These technological enhancements also lead to reduced procedure times and improved patient comfort, further driving the adoption of apheresis in clinical settings. Furthermore, the rising prevalence of chronic and autoimmune diseases fuels the demand for apheresis procedures. Conditions such as cancer, autoimmune disorders, and hematologic diseases often require targeted removal or collection of specific blood components to manage symptoms or facilitate treatments. Apheresis serves as a crucial therapeutic intervention by allowing the selective extraction of disease-related components, contributing to disease management and improving patient outcomes. As the burden of chronic diseases continues to increase, the demand for apheresis procedures as a therapeutic option is expected to grow. Besides, the widespread therapeutic applications for apheresis broaden its market potential. Beyond traditional uses, apheresis is finding applications in neurology, nephrology, and hematology, among other medical specialties. This diversification of applications positions apheresis as a versatile and valuable tool in various healthcare scenarios, contributing to its sustained market growth. Additionally, the growing awareness among healthcare professionals about the benefits of apheresis in managing a wide range of medical conditions further propels its adoption.

Japan Apheresis Market Segmentation:

Component Insights:

• Plasma (Plasmapheresis)
• Platelets (Plateletpheresis)
• Leukocytes (Leukapheresis or Leukopheresis)
• Lymphocytes (Lymphopheresis or Lymphapheresis)
• RBC's (Erythropheresis)

Product Insights:

• Devices
• Disposables and Reagents
• Software

Technology Insights:

• Centrifugation
• Membrane Separation
• Selective Adsorption

Procedure Insights:

• Donor/Automated Apheresis
• Therapeutic Apheresis

Application Insights:

• Renal Disorders
• Hematological Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

End User Insights:

• Blood Centers
• Hospitals
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan apheresis market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan apheresis market?
• What is the breakup of the Japan apheresis market on the basis of component?
• What is the breakup of the Japan apheresis market on the basis of product?
• What is the breakup of the Japan apheresis market on the basis of technology?
• What is the breakup of the Japan apheresis market on the basis of procedure?
• What is the breakup of the Japan apheresis market on the basis of application?
• What is the breakup of the Japan apheresis market on the basis of end user?
• What are the various stages in the value chain of the Japan apheresis market?
• What are the key driving factors and challenges in the Japan apheresis?
• What is the structure of the Japan apheresis market and who are the key players?
• What is the degree of competition in the Japan apheresis market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Apheresis Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Apheresis Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Apheresis Market - Breakup by Component

• 6.1 Plasma (Plasmapheresis)
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Platelets (Plateletpheresis)
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Leukocytes (Leukapheresis or Leukopheresis)
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 RBC's (Erythropheresis)
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)

7 Japan Apheresis Market - Breakup by Product

• 7.1 Devices
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Disposables and Reagents
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Software
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)

8 Japan Apheresis Market - Breakup by Technology

• 8.1 Centrifugation
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Membrane Separation
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Selective Adsorption
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)

9 Japan Apheresis Market - Breakup by Procedure

• 9.1 Donor/Automated Apheresis
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Therapeutic Apheresis
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)

10 Japan Apheresis Market - Breakup by Application

• 10.1 Renal Disorders
  • 10.1.1 Overview
  • 10.1.2 Historical and Current Market Trends (2019-2024)
  • 10.1.3 Market Forecast (2025-2033)
• 10.2 Hematological Disorders
  • 10.2.1 Overview
  • 10.2.2 Historical and Current Market Trends (2019-2024)
  • 10.2.3 Market Forecast (2025-2033)
• 10.3 Neurological Disorders
  • 10.3.1 Overview
  • 10.3.2 Historical and Current Market Trends (2019-2024)
  • 10.3.3 Market Forecast (2025-2033)
• 10.4 Autoimmune Disorders
  • 10.4.1 Overview
  • 10.4.2 Historical and Current Market Trends (2019-2024)
  • 10.4.3 Market Forecast (2025-2033)
• 10.5 Others
  • 10.5.1 Historical and Current Market Trends (2019-2024)
  • 10.5.2 Market Forecast (2025-2033)

11 Japan Apheresis Market - Breakup by End User

• 11.1 Blood Centers
  • 11.1.1 Overview
  • 11.1.2 Historical and Current Market Trends (2019-2024)
  • 11.1.3 Market Forecast (2025-2033)
• 11.2 Hospitals
  • 11.2.1 Overview
  • 11.2.2 Historical and Current Market Trends (2019-2024)
  • 11.2.3 Market Forecast (2025-2033)
• 11.3 Others
  • 11.3.1 Historical and Current Market Trends (2019-2024)
  • 11.3.2 Market Forecast (2025-2033)

12 Japan Apheresis Market - Competitive Landscape

• 12.1 Overview
• 12.2 Market Structure
• 12.3 Market Player Positioning
• 12.4 Top Winning Strategies
• 12.5 Competitive Dashboard
• 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

• 13.1 Company A
  • 13.1.1 Business Overview
  • 13.1.2 Product Portfolio
  • 13.1.3 Business Strategies
  • 13.1.4 SWOT Analysis
  • 13.1.5 Major News and Events
• 13.2 Company B
  • 13.2.1 Business Overview
  • 13.2.2 Product Portfolio
  • 13.2.3 Business Strategies
  • 13.2.4 SWOT Analysis
  • 13.2.5 Major News and Events
• 13.3 Company C
  • 13.3.1 Business Overview
  • 13.3.2 Product Portfolio
  • 13.3.3 Business Strategies
  • 13.3.4 SWOT Analysis
  • 13.3.5 Major News and Events
• 13.4 Company D
  • 13.4.1 Business Overview
  • 13.4.2 Product Portfolio
  • 13.4.3 Business Strategies
  • 13.4.4 SWOT Analysis
  • 13.4.5 Major News and Events
• 13.5 Company E
  • 13.5.1 Business Overview
  • 13.5.2 Product Portfolio
  • 13.5.3 Business Strategies
  • 13.5.4 SWOT Analysis
  • 13.5.5 Major News and Events

14 Japan Apheresis Market - Industry Analysis

• 14.1 Drivers, Restraints, and Opportunities
  • 14.1.1 Overview
  • 14.1.2 Drivers
  • 14.1.3 Restraints
  • 14.1.4 Opportunities
• 14.2 Porters Five Forces Analysis
  • 14.2.1 Overview
  • 14.2.2 Bargaining Power of Buyers
  • 14.2.3 Bargaining Power of Suppliers
  • 14.2.4 Degree of Competition
  • 14.2.5 Threat of New Entrants
  • 14.2.6 Threat of Substitutes
• 14.3 Value Chain Analysis

15 Appendix